α,β-Methyleneadenosine 5'-triphosphate trisodium salt
Tocris Bioscience, part of Bio-Techne | Catalog # 3209
Non-selective P2 agonist
Key Product Details
Description
Non-selective P2 agonist
Alternative Names
α,β-meATP
Product Description
α,β-Methyleneadenosine 5'-triphosphate trisodium salt is a P2-purinoceptor agonist. Also shown to inhibit adenylate cyclase (Ki = 0.5 mM).Product Specifications
Molecular Weight
571.15
Formula
C11H15N5Na3O12P3
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
α,β-Methyleneadenosine 5'-triphosphate trisodium salt
CAS Number
1343364-54-4
PubChem ID
90488813
InChI Key
CBAGKCWFSRTVER-MTQUBGKESA-K
SMILES
O[C@@H]1[C@@H](COP(CP([O-])(OP([O-])(O)=O)=O)([O-])=O)O[C@@H](N3C2=NC=NC(N)=C2N=C3)[C@@H]1O.[Na+].[Na+].[Na+]
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 57.12 | 100 |
Preparing Stock Solutions
for α,β-Methyleneadenosine 5'-triphosphate trisodium salt
The following data is based on the product molecular weight 571.15
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.75 mL | 8.75 mL | 17.51 mL |
| 5 mM | 0.35 mL | 1.75 mL | 3.50 mL |
| 10 mM | 0.18 mL | 0.88 mL | 1.75 mL |
| 50 mM | 0.04 mL | 0.18 mL | 0.35 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Burnstock and Kennedy Is there a basis for distinguishing two types of P2-purinoceptor? Gen.Pharmacol 1985 PMID: 2996968
- Krug α,β-Methylene-adenosine 5'-triphosphate. J.Biol.Chem. 1973 PMID: 4686923
Product Specific Notices for α,β-Methyleneadenosine 5'-triphosphate trisodium salt
For research use only
Loading...
Loading...
Loading...